Ventricular	ventricular	O	O	OTHERS	I
tachyarrhythmias	tachyarrhythmias	O	O	OTHERS	I
during	during	O	O	O	O
cesarean	cesarean	O	O	O	O
section	section	O	O	O	O
after	after	O	O	O	O
ritodrine	ritodrine	O	O	OTHERS	I
therapy	therapy	O	O	O	O
:	:	O	O	O	O
interaction	interaction	O	O	O	O
with	with	O	O	O	O
anesthetics	anesthetics	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
case	case	O	O	O	O
illustrates	illustrates	O	O	O	O
that	that	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
ritodrine	ritodrine	O	O	OTHERS	I
for	for	O	O	O	O
preterm	preterm	O	O	OTHERS	I
labor	labor	O	O	OTHERS	I
may	may	O	O	O	O
risk	risk	O	O	O	O
interactions	interactions	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
residual	residual	O	O	O	O
betamimetic	betamimetic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
ritodrine	ritodrine	O	O	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
anesthetics	anesthetics	O	O	O	O
during	during	O	O	O	O
cesarean	cesarean	O	O	O	O
section	section	O	O	O	O
.	.	O	O	O	O

Such	such	O	O	O	O
interactions	interactions	O	O	O	O
may	may	O	O	O	O
result	result	O	O	O	O
in	in	O	O	O	O
serious	serious	O	O	O	O
cardiovascular	cardiovascular	O	O	OTHERS	I
complications	complications	O	O	OTHERS	I
even	even	O	O	O	O
after	after	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
infusion	infusion	O	O	O	O
of	of	O	O	O	O
ritodrine	ritodrine	O	O	OTHERS	I
.	.	O	O	O	O

Preoperative	preoperative	O	O	O	O
assessment	assessment	O	O	O	O
should	should	O	O	O	O
focus	focus	O	O	O	O
on	on	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
status	status	O	O	O	O
and	and	O	O	O	O
serum	serum	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
.	.	O	O	O	O

Delaying	delaying	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
anesthesia	anesthesia	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
considered	considered	O	O	O	O
whenever	whenever	O	O	O	O
possible	possible	O	O	O	O
.	.	O	O	O	O

Careful	careful	O	O	O	O
fluid	fluid	O	O	O	O
administration	administration	O	O	O	O
and	and	O	O	O	O
cautious	cautious	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
titrated	titrated	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
are	are	O	O	O	O
advised	advised	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
delivery	delivery	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
infant	infant	O	O	O	O
,	,	O	O	O	O
there	there	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
no	no	O	O	O	O
contraindication	contraindication	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
alpha-adrenergic	alpha-adrenergic	O	O	O	O
vasopressor	vasopressor	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
treat	treat	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
with	with	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

